Caleres (NYSE:CAL) Reports Sales Below Analyst Estimates In Q2 CY2026 Earnings, But Stock Soars 5.2%

Caleres (NYSE: CAL) reported Q2 CY2026 sales of $695.5M, up 5.6% YoY but below estimates. Non-GAAP EPS of $0.47 beat forecasts by 27%. Revenue growth has averaged 2.4% annually over five years, with flat performance in the last two years. Operating margin improved to 11.2%, up 8.6 percentage points YoY. EPS declined 12.6% annually over five years despite revenue growth. Stock rose 5.2% post-results.

Original reporting
Published Sep 9, 2026, 1:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 9, 2026, 1:34 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Caleres (NYSE:CAL) Reports Sales Below Analyst Estimates In Q2 CY2026 Earnings, But Stock Soars 5.2% — source image
Decision brief

The 30-second read

$CALBullishHigh
01

Why it matters

The earnings beat sparked a 5.2% stock surge, indicating immediate trader interest; however, guidance shortfalls may temper longer‑term sentiment.

02

Market read

First‑report earnings surprise for a mid‑cap consumer discretionary stock, generating short‑term trading opportunity.

03

What to watch

Rising interest expenses and flat revenue growth over two years may pressure margins going forward.

Relevance 8/10Novelty 8/10Timing: post-earnings today

Background

Caleres reported Q2 CY2026 results with revenue up 5.6% YoY but missing consensus, while EPS beat and operating margin improved.

Company-level read

Ticker impact

$CALBullishHigh confidence
Context

Q2 2026 earnings beat EPS expectations and the stock jumped 5.2% after release.

Expected impact

Expect continued upside pressure in the near term as investors digest the beat.

Evidence & confidence

The beat was fresh, the stock already rose 5.2% on the news, and guidance remains modest, suggesting momentum may persist.

Market effects

Footwear and broader consumer discretionary may see modest lift as a mid‑cap beats expectations.

U.S. consumer discretionary stocks could see short‑term buying pressure.

Limited to U.S. markets; no direct global macro effect.

Counterpoint

Despite the beat, revenue missed estimates and long‑term growth remains weak, suggesting the rally could be short‑lived.

Key entities

  • Caleres

    Footwear retailer (NYSE:CAL) reporting Q2 earnings.

Related articles

$CALHighAI 8/10

Caleres (CAL) Stock Lags Behind Its Brand Portfolio’s Surge

Caleres (CAL) reported Q2 2026 results with net sales up 5.6% YoY to $695.5M, but organic sales excluding Stuart Weitzman declined 0.8%. Brand Portfolio sales grew 8.2% with margin expansion, while Famous Footwear sales fell 6.3%. Adjusted EPS rose to $0.47. The company raised full-year EPS guidance to $1.50-$1.65. Management highlights strategic shift to premium brands and higher-margin channels.

$CALHighAI 8/10

Caleres (CAL) Stock Lags Behind Its Brand Portfolio’s Surge

Caleres (CAL) reported Q2 net sales of $695.5M, up 5.6%, and adjusted EPS of $0.47, up from $0.35. Its brand portfolio, including Sam Edelman and Stuart Weitzman, saw sales rise 23.6%, while Famous Footwear sales fell 6.3%. The company raised its full-year guidance but cited inventory and tariff uncertainties.

$CALMedAI 9/10

Caleres (CAL) Q2 2026 Earnings Call Transcript

Caleres (CAL) reported Q2 2026 net sales of $695.5M, up 5.6%, with adjusted EPS of $0.47. Brand portfolio sales rose 23.6%, while Famous Footwear sales fell 6.3%. The company raised FY 2026 adjusted EPS guidance to $1.50-$1.65. Management cited growth in international sales and brand portfolio but warned of softness in certain Famous Footwear categories and tariff uncertainties.

$CALHighAI 8/10

Caleres (CAL) Stock Trades Up, Here Is Why

Caleres (CAL) shares rose 9.7% after reporting Q2 earnings beat with $695.5M net sales and $0.47 adjusted EPS, raising full-year guidance. Shares later cooled to $12.63, up 5%. The company guided full-year net sales growth in low-to-mid-single digits and adjusted EPS to $1.50-$1.65.